Erdafitinib treatment in Brazilian patients with metastatic urothelial carcinoma (mUC): real-world evidence from an Expanded Access Program.
Fernando Sabino Marques MonteiroAdriano Gonçalves E SilvaAndrea Juliana P de S GomesCarolina DutraNaira Oliveira FerreiraRodrigo Coutinho MarianoFabio A SchutzPublished in: Therapeutic advances in medical oncology (2021)
This first real-world evidence report of heavily treated patients with mUC confirms the efficacy and safety of erdafitinib in a disease setting with a lack of treatment options.
Keyphrases